Form 8-K ImmunoGen, Inc. For: May 03
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/4/2026
- Wall Street rallies, Dow closes at record on Iran talks optimism
- Fed's Williams says rate hikes possible if inflation persists
- Citi says buy these 3 chip stocks on pullback
- Microsoft joins, Broadcom exits Goldman's top-stocks list
- Deutsche Bank raises S&P 500 earnings estimates on the back of the solid Q2 beats
- After-Hours Stock Movers: PLTR, SNAP, ON, ICHR, WGS, WHR
- After-Hours Stock Movers: AAPL, AMZN, COIN, RBLX, RDDT, AXTI, FND, WU, GDDY
- After-Hours Stock Movers: META, MSFT, CMG, SBUX, CVNA, LRCX, FTNT, QCOM, TDOC
- After-Hours Stock Movers: F, BE, STX, WDC, KLAC, SWKS, NXPI, CSGP, ENPH
- After-Hours Stock Movers: FFIV, CDNS, APLD, RMBS, ESI, SANM
Immunogen Inc. (IMGN) Elahere Data 'Simply Mirvelous!' - BMO
May 3, 2023 7:39 AM EDTBMO Capital analyst Etzer Darout reiterated an Outperform rating and $19.00 price target on Immunogen Inc. (NASDAQ: IMGN) following positive phase 3 data on ELAHERE. The analyst called the results "simply mirvelous!'
The analyst commented, "This morning IMGN announced that the Phase 3 MIRASOL trial studying... More
Immunogen Inc. (IMGN) PT Raised to $15 at Truist Securities on 'Home Run' Data
May 3, 2023 7:35 AM EDTTruist Securities analyst Asthika Goonewarden raised the price target on Immunogen Inc. (NASDAQ: IMGN) to $15.00 (from $11.00) while maintaining a Buy rating, calling today's data a "home run."
The analyst commented, "We view the topline data reported this morning as a home run. MIRASOL not... More
